Celularity
Price & Volume
Stats
See more52W Range | $1.01-$4.35 |
Market Cap | $40.3M |
Shares Short | 433,481 |
Financials
See moreRevenue (12 Mos) | $40.5M |
Revenue Growth (YoY) | -43.2% |
Gross Profit (12 Mos) | $20.5M |
Diluted EPS | -$3.33 |
News
See moreYahoo Finance • 29 days ago
NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products
Yahoo Finance • 3 months ago
Organogenesis drops as Medicare to pull skin substitute LCDs (update)
Yahoo Finance • 6 months ago
Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease
Yahoo Finance • 7 months ago
Here are the top movers in Tuesday's session.
About
CEO | Dr. Robert Joseph Hariri M.D., Ph.D. |
Address | 170 Park Avenue, Florham Park, NJ, United States, 07932 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 123 |
